• Research That Leads to Innovation

    Scientific study of hemangiomas, other rare vascular tumors and vascular malformations is an important and growing area of research. Breakthroughs in the laboratory will help the medical community better understand the conditions, develop new treatments and improve the quality of life for patients.

    Laboratory research at Cincinnati Children’s provides the foundation for innovative treatments. Once a month, researchers from the lab get together with researchers and physicians in the clinic to discuss the latest findings during the Vascular Clinical Basic Science Research Conference.

    Current areas of focus in the lab include:

    • Finding new drug targets for hemangiomas: In the past, physicians thought that hemangiomas formed only from endothelial cells - the thin layer of cells that line the interior surface of blood vessels. But based on cell migration patterns, Cincinnati Children’s researcher Kristin Melton thinks that neural crest cells (which give rise to a variety of tissues) may actually form portions of the hemangioma, or might direct the endothelial cells to form them. In cultures in the lab, Melton is observing signaling between neural crest cells and hemangioma cells to learn how the two types of cells communicate, and how this leads to hemangioma development. Understanding how hemangiomas originate will produce new targets for therapeutic interventions.
    • Learning more about vascular development: Knowing how genes regulate normal development of the vascular system will help us to understand genetic causes and possible treatments for human vascular disorders. Researcher Saulius Sumanas uses zebrafish embryos as a model system to study how vascular systems develop. (Similar genes control both human and zebrafish vascular development.) Sumanas is investigating detailed mechanisms of blood vessel formation and identifying new genes participating in these processes. Ultimately, he hopes to find new genes that can be targeted for treatment of vascular disorders.
  • Developmental Biology

    Scientists in the Division of Developmental Biology at Cincinnati Children’s are focused on uncovering the basis of human birth defects so they can be prevented or corrected.

    Read more
  • Pulmonary Biology

    The Division of Pulmonary Biology is part of the Section of Neonatology, Perinatal and Pulmonary Biology and a partner in the Perinatal Institute, working closely with the divisions of Neonatology and Perinatal Biology.

    Read more
  • More Information

    If you would like more information regarding research at Cincinnati Children's in Hemangioma and Vascular Malformations, please contact John Perentesis MD, Director of Oncology, at john.perentesis@cchmc.org or call 513-636-8241.